San Francisco expands Pfizer vaccine eligibility for residents 12 and older

San Francisco is making significant strides in its COVID-19 vaccination efforts, with eligibility now extended to individuals aged 12 and older. During a recent government meeting, Director Colfax highlighted the city's ongoing rollout of the Pfizer vaccine, emphasizing the availability of multiple vaccination options for residents. This initiative is part of a broader strategy to maintain public health as the city continues to navigate the pandemic.

As of now, San Francisco has reported a total of 36,487 COVID-19 cases and 541 related deaths. However, the city is experiencing a notable decline in infection rates, with current statistics showing just over 2 cases per 100,000 residents. This improvement is attributed to effective safety measures and a robust vaccination campaign, which has seen 76% of residents aged 16 and older receive at least one vaccine dose.

The meeting also addressed the city's current status in the state's tier system, with San Francisco now in the yellow tier, reflecting low infection rates. Director Colfax expressed optimism about the city's ability to balance reopening with vaccination efforts, noting that the reproductive rate of the virus is currently at 0.79, the lowest it has been in some time.

In addition to vaccination updates, the meeting acknowledged the leadership of Dr. Philip, who was recently confirmed as the health officer, and recognized the contributions of Maria X Martinez in promoting equity within the health department.

As San Francisco approaches the milestone of administering one million vaccine doses, officials remain committed to monitoring health data closely to ensure the continued safety and well-being of the community. The city's proactive approach to vaccination and public health measures is paving the way for a hopeful future as it emerges from the pandemic.